Supply Chain

San Francisco-based McKesson Corp. will pay $150 million — a record high amount — as part of a Controlled Substances Act civil penalty settlement to resolve allegations it failed to report suspicious orders of painkillers.

Here are the five latest drugs and medical devices approved by the Food and Drug Administration.

Israel-based Teva Pharmaceutical Industries earned approval from the Food and Drug Administration for its abuse-deterrent painkiller Vantrelatmer.

The Food and Drug Administration approved the first generic version of Jazz Pharmaceutical's drug Xyrem to treat patients with narcolepsy.

Andrew Left, a well-known short seller at Citron Research, predicts generic drug firm Lannett will be the first drugmaker to go bankrupt amid ongoing drug pricing scrutiny, according to a report released Tuesday.

When asked how the drug industry should react to President-elect Donald Trump's vow to "bring down drug prices," Pfizer CEO Ian Read had an unlikely response: Raise drug prices.

Cambridge, Mass.-based Biogen entered a licensing agreement with Forward Pharma for the Danish drugmaker's multiple sclerosis treatments.

Hospitals in the Washington, D.C. area have voiced an urgent call to increase collections of blood supplies as they prepare for potential emergencies during the upcoming presidential inauguration weekend, reports WTOP.

In a recent press release, HPS, a group purchasing organization (GPO) with more than 3,600 members, including 144 acute care and 1,466 non-acute care facilities, in 20 states, signed an agreement with Resource Optimization & Innovation (ROi), a provider-owned supply chain…

The U.S. Supreme Court on Friday agreed to review a dispute between Basel, Switzerland-based Novartis and Thousand Oaks, Calif.-based Amgen on whether drug companies must wait six months after winning regulatory approval before selling "copycat" versions of biologic drugs, reports…